CA
CERE

Continuum Advisory’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Continuum Advisory’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$695 – 2042
2024
Q2 		$695 Hold
17
– – ﹤0.01% 1541
2024
Q1 		$719 Buy
+17
New +$719 ﹤0.01% 1535